Share on StockTwits
 

Illumina (NASDAQ:ILMN) is scheduled to be releasing its earnings data on Tuesday, January 28th. Parties interested in participating in the company’s conference call can do so using this link.

Illumina (NASDAQ:ILMN) opened at 138.62 on Monday. Illumina has a one year low of $48.00 and a one year high of $148.48. The stock’s 50-day moving average is $113. and its 200-day moving average is $91.07. The company has a market cap of $17.521 billion and a P/E ratio of 171.96.

A number of analysts have recently weighed in on ILMN shares. Analysts at Leerink Swann raised their price target on shares of Illumina from $110.00 to $140.00 in a research note to investors on Friday, January 17th. On a related note, analysts at Bank of America Corp. raised their price target on shares of Illumina from $125.00 to $165.00 in a research note to investors on Friday, January 17th. Finally, analysts at Robert W. Baird raised their price target on shares of Illumina from $87.00 to $137.00 in a research note to investors on Friday, January 17th. Seven analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $113.11.

In other Illumina news, CEO Jay T. Flatley sold 30,000 shares of the company’s stock on the open market in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $142.30, for a total value of $4,269,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.